Changes in Type 2 Diabetes Medications Among Primary Care Patients After California's 2022 Medicaid Expansion
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.California
Area Of Science
- Health Services Research
- Diabetes Management
- Health Equity
Background
- California's Medi-Cal expansion in May 2022 provided full-scope coverage to low-income undocumented immigrants aged 50+.
- This policy change granted access to advanced type 2 diabetes (T2D) medications.
- The study investigates the impact of this expansion on prescription patterns for T2D therapies.
Purpose Of The Study
- To assess the effect of Medi-Cal expansion on the uptake of newer T2D medications among older undocumented immigrants.
- To compare prescription trends between newly eligible older undocumented immigrants, younger undocumented immigrants, and documented patients.
Main Methods
- Analysis of patient records from two Los Angeles County FQHCs (January 2019–June 2023).
- Utilized generalized linear mixed models to compare prescription likelihood and changes over time.
- Included 20,420 encounters and 4,601 patients across three groups: older undocumented, younger undocumented, and documented.
Main Results
- Initially, undocumented patients (both older and younger) had lower odds of receiving newer T2D drugs compared to documented patients.
- Prescriptions for newer T2D medications increased across all groups over time.
- The monthly increase in prescription odds for newer T2D drugs was 6% higher in the older undocumented group than in the documented group.
Conclusions
- Medi-Cal expansion significantly influenced T2D medication prescribing for older undocumented immigrants.
- Despite a lower initial prescription rate, older undocumented immigrants reached similar prescription levels as documented patients by the study's end.
- The findings highlight the positive impact of insurance expansion on access to advanced diabetes care.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...